Insmed (INSM) Price to Sales (2009 - 2026)
Insmed's (INSM) Price to Sales came in at 16.39 for Q3 2026, down 76.1% from 68.48 a year earlier and down 19.9% from the prior quarter.
Powered by 
Analysis
Insmed (INSM) Price to Sales (2009 - 2026) Analysis & Trends
For FY2025, Insmed's Price to Sales stood at 61.49, up 80.6% from FY2024.
- Annual Price to Sales has increased for three consecutive years.
- In prior years, Insmed's Price to Sales was 34.05 in FY2024 (+126.6%), 15.03 in FY2023 (+36.0%), 11.05 in FY2022 (-35.6%) and 17.16 in FY2021 (-17.5%).
- The Q3 2026 figure stands as the lowest quarterly Price to Sales since Q1 2024.
- On a year-over-year basis, Price to Sales increased in six of the last eight quarters, with growth averaging 51.3%.
- The strongest year-over-year quarter for Price to Sales in the past five years was Q2 2024, with growth of 204.0%; the weakest was Q3 2026, with a decline of 76.1%.
- According to Business Quant data, Price to Sales for the three prior quarters was 20.46 (Q2 2026), 43.20 (Q1 2026) and 61.49 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Insmed | 26.21 Bn | 21.25 Bn | 446.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 16.47 |
| Jun 30, 2026 | 20.46 |
| Mar 31, 2026 | 43.20 |
| Dec 31, 2025 | 61.49 |
| Sep 30, 2025 | 68.48 |
| Jun 30, 2025 | 53.37 |
| Mar 31, 2025 | 36.42 |
| Dec 31, 2024 | 34.05 |
| Sep 30, 2024 | 38.07 |
| Jun 30, 2024 | 33.98 |
| Mar 31, 2024 | 12.78 |
| Dec 31, 2023 | 15.03 |
| Sep 30, 2023 | 12.86 |
| Jun 30, 2023 | 11.18 |
| Mar 31, 2023 | 9.03 |
| Dec 31, 2022 | 11.05 |
| Sep 30, 2022 | 10.83 |
| Jun 30, 2022 | 10.69 |
| Mar 31, 2022 | 13.93 |
| Dec 31, 2021 | 17.16 |
API Access
Insmed Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=INSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "INSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=INSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();